Insulin-Like Growth Factor-1 (IGF-1) Reduces ischemic changes and increases circulating angiogenic factors in experimentally - induced myocardial infarction in rats
Open Access
- 1 January 2011
- journal article
- Published by Publiverse Online S.R.L in Vascular Cell
- Vol. 3 (1), 13
- https://doi.org/10.1186/2045-824x-3-13
Abstract
BackgroundCoronary artery disease is a global health concern in the present day with limited therapies. Extensive efforts have been devoted to find molecular therapies to enhance perfusion and function of the ischemic myocardium. Aim of the present study was to look into the effects of insulin like growth factor -1 (IGF-1) on circulating angiogenic factors after myocardial ischemia in rats. MethodsAdult male Sprague-Dawley rats were randomly divided into 10-days control, myocardial infarction, IGF-1 alone (2 μg/rat/day) and ISO+IGF-1 groups. Isoproterenol (ISO), a synthetic catecholamine was used to induce myocardial infarction. Serum transforming growth factor-β (TGF-β) and vascular endothelial growth factor (VEGF) levels were checked after 10-days of IGF-1 administration. ResultsThere was a significant increase in heart weight after IGF-1 treatment. A significant increase in cardiac enzyme level (CK-MB and LDH) was seen in isoproterenol treated rats when compared to control group. IGF-1treatment induced a significant increase in serum angiogenic factors, IGF-1, VEGF and TGF beta levels. IGF-1 also reduced the ischemic changes in the myocardium when compared to the isoproterenol alone treated group. ConclusionsIn conclusion, treatment with insulin-like growth factor-1 (IGF-1) in myocardial infarction significantly increased circulating angiogenic growth factors like IGF-1, VEGF and TGF beta thus, protecting against myocardial ischemia.Keywords
This publication has 33 references indexed in Scilit:
- Stimulation of functional vessel growth by gene therapyIntegrative Biology, 2010
- A new, precise definition of acute myocardial infarctionCleveland Clinic Journal of Medicine, 2009
- Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: A biochemical and histoarchitectural evaluationExperimental and Toxicologic Pathology, 2008
- Simultaneous Administration of Insulin‐Like Growth Factor‐1 and Darbepoetin Alfa Protects the Rat Myocardium Against Myocardial Infarction and Enhances AngiogenesisClinical and Translational Science, 2008
- Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial InjuryToxicologic Pathology, 2008
- Therapeutic myocardial angiogenesisMicrovascular Research, 2007
- Grape seed proanthocyanidins ameliorates isoproterenol-induced myocardial injury in rats by stabilizing mitochondrial and lysosomal enzymes: An in vivo studyLife Sciences, 2007
- MCP-1 mediates TGF-β–induced angiogenesis by stimulating vascular smooth muscle cell migrationBlood, 2006
- Regulation of vascular endothelial growth factor expression by insulin-like growth factor IDiabetes, 1997
- Mechanisms of angiogenesisNature, 1997